2026-08415Notice

NRC Approves Handover of SHINE's Isotope Factory License to New Owners

Published Date: 4/30/2026

Notice

Summary

The Nuclear Regulatory Commission just gave the green light for SHINE Technologies to transfer its construction permit for the SHINE Medical Isotope Production Facility to a new company called SHINE Chrysalis, LLC. This change also involves a new parent company, SHINE Chrysalis Holdings, LLC, and is effective for one year starting April 22, 2026. This move keeps the project on track without any extra costs or delays for now.

No Economic Impacts Identified for this Document

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Effective Date
Published Date
4/22/2026
4/30/2026

Department and Agencies

Department
Independent Agency
Agency
Nuclear Regulatory Commission
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register